Liquidia to Report Second Quarter 2021 Financial Results on August 10, 2021
03 August 2021 - 9:00PM
Liquidia Corporation (NASDAQ: LQDA) announced today that it will
report its second quarter 2021 financial results on Tuesday, August
10, 2021. The company will host a webcast and conference call at
8:30 a.m. Eastern Daylight Time to discuss financial results and
provide a corporate update.
The live call may be accessed by dialing
1-877-707-8711 (domestic) or 1-857-270-6219 (international) and
entering the conference code: 4638099. A webcast of the call will
be available and archived on Liquidia’s website at
https://liquidia.com/index.php/investors/events-and-presentations.
About Liquidia
CorporationLiquidia Corporation is a biopharmaceutical
company focused on the development and commercialization of
products in pulmonary hypertension and other applications of its
PRINT® Technology. The company operates through its two wholly
owned subsidiaries, Liquidia Technologies, Inc. and Liquidia PAH,
LLC. Liquidia Technologies is developing LIQ861, an inhaled dry
powder formulation of treprostinil for the treatment of PAH.
Liquidia PAH provides the commercialization for rare disease
pharmaceutical products, such as Treprostinil Injection. For more
information, please visit www.liquidia.com.
Contact InformationMedia
& Investors:Jason AdairVice President, Corporate
Development and Strategy919.328.4400jason.adair@liquidia.com
Liquidia (NASDAQ:LQDA)
Historical Stock Chart
From Apr 2024 to May 2024
Liquidia (NASDAQ:LQDA)
Historical Stock Chart
From May 2023 to May 2024